Surgical Science Sweden AB (publ) (LON: 0AAU)

Market Cap	650.66M
Revenue (ttm)	63.25M
Net Income (ttm)	14.22M
Shares Out	n/a
EPS (ttm)	0.28
PE Ratio	45.75
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	73
Average Volume	5,990
Open	173.80
Previous Close	176.10
Day's Range	173.80 - 173.80
52-Week Range	8.13 - 14.18
Beta	0.97
RSI	64.81
Earnings Date	Feb 19, 2025

About Surgical Science Sweden AB

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy tra...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1997
• Employees: 260
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0AAU

Financial Performance

In 2023, Surgical Science Sweden AB's revenue was 882.85 million, an increase of 10.01% compared to the previous year's 802.54 million. Earnings were 233.97 million, an increase of 24.47%.

Financial numbers in SEK